AKTX
Akari Therapeutics·NASDAQ
--
--(--)
--
--(--)
AKTX Filings
Filing Date
Form Description
Form Type
2026-03-17
Form 8-K - Current report
Key Events
2026-03-17 · Key Events
Form 8-K - Current report
2026-03-16
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-16 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-04
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-04 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-04
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-04 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-04
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-04 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-02
Form 8-K - Current report
Key Events
2026-03-02 · Key Events
Form 8-K - Current report
2026-02-02
Form DEF 14A - Other definitive proxy statements
Key Events
2026-02-02 · Key Events
Form DEF 14A - Other definitive proxy statements
2026-01-30
Form EFFECT - Notice of Effectiveness
2026-01-30 ·
Form EFFECT - Notice of Effectiveness
2026-01-27
Form CORRESP - Correspondence
SEC Inquiries
2026-01-27 · SEC Inquiries
Form CORRESP - Correspondence
2026-01-27
Form UPLOAD - SEC-generated letter
SEC Inquiries
2026-01-27 · SEC Inquiries
Form UPLOAD - SEC-generated letter
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
